Emerging technologies in point-of-care molecular diagnostics for resource-limited settings

Expert Review of Molecular Diagnostics

Volumn 14, Issue 5, 2014, Pages 525-534

  Peeling, Rosanna W ^a   Mcnerney, Ruth ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

In vitro diagnostics; Infectious diseases; Molecular diagnosis; Point of care; Resource limited settings

Indexed keywords

NANOPARTICLE;

ANTIBIOTIC RESISTANCE; ASYMPTOMATIC INFECTION; CHILDHOOD DISEASE; DIAGNOSTIC TEST; DISEASE ELIMINATION; DISEASE TRANSMISSION; ELECTRICITY; ENERGY RESOURCE; FEVER; FINANCIAL MANAGEMENT; HEALTH CARE; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALARIA; MARKETING; MEDICAL TECHNOLOGY; MOLECULAR DIAGNOSIS; MOLECULAR DIAGNOSTICS; NANOSENSOR; NEGLECTED DISEASE; PNEUMONIA; POINT OF CARE TESTING; REVIEW; SCALE UP; SEPSIS; SEXUALLY TRANSMITTED DISEASE; SHELF LIFE; THERMOSTABILITY; TROPIC CLIMATE; TROPICAL DISEASE; TUBERCULOSIS; COMMUNICABLE DISEASES; DEVELOPING COUNTRY; ECONOMICS; POINT OF CARE SYSTEM; PROCEDURES;

COMMUNICABLE DISEASES; DEVELOPING COUNTRIES; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; POINT-OF-CARE SYSTEMS;

EID: 84901265618     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.2014.915748     Document Type: Review

References (81)

1. Harrington M, Morgan S, Syed J. 2009 Report on tuberculosis. research funding trends, 2005-2008. 2nd edition. TAG; NY, USA: 2010
2. Petti CA, Polage CR, Quinn TC, et al. Laboratory medicine in Africa: A barrier to effective health care. Clin Infect Dis 2006; 42(3):377-82 (Pubitemid 43122314
3. Berkelman R, Cassell G, Specter S, et al. The "Achilles heel" of global efforts to combat infectious diseases. Clin Infect Dis 2006;42(10):1503-4
4. Peeling RW, Mabey D. Point-of-care tests for diagnosing infections in the developing world. Clin Microbiol Infect 2010;16(8): 1062-9
5. Greenwald JL, Burstein GR, Pincus J, Branson B. A rapid review of rapid HIV antibody tests. Curr Infect Dis Rep 2006; 8(2):125-31
6. Franco-Paredes C, Tellez I, del Rio C. Rapid HIV testing: A review of the literature and implications for the clinician. Curr HIV/AIDS Rep 2006;3(4): 169-75 (Pubitemid 44657375
7. Bell D, Peeling RW. Pacific/TDR WH-ROftW. Evaluation of rapid diagnostic tests: Malaria. Nat Rev Microbiol 2006; 4(9 Suppl):S34-8
8. Murray CK, Gasser RA Jr, Magill AJ, Miller RS. Update on rapid diagnostic testing for malaria. Clin Microbiol Rev 2008;21(1):97-110 (Pubitemid 351160011
9. Steingart KR, Flores LL, Dendukuri N, et al. Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: An updated systematic review and meta-Analysis. PLoS Med 2011;8(8):e1001062
10. Yager P, Domingo GJ, Gerdes J. Point-of-care diagnostics for global health. Annu Rev Biomed Eng 2008;10:107-44
11. Schito M, Peter TF, Cavanaugh S, et al. Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis. J Infect Dis 2012; 205(Suppl 2):S169-80
12. Bissonnette L, Bergeron MG. Diagnosing infections-current and anticipated technologies for point-of-care diagnostics and home-based testing. Clin Microbiol Infect 2010;16(8):1044-53
13. Dheda K, Ruhwald M, Theron G, et al. Point-of-care diagnosis of tuberculosis: Past, present and future. Respirology 2013;18(2): 217-32
14. Niemz A, Ferguson TM, Boyle DS. Point-of-care nucleic acid testing for infectious diseases. Trends Biotechnol 2011; 29(5):240-50
15. UNITAID. Tuberculosis diagnostics technology and market landscape. UNITAID; Geneva, Switzerland: 2013
16. UNITAID. HIV/AIDS diagnostic technology landscape. UNITAID; Geneva, Switzerland: 2013
17. Abubakar I, Zignol M, Falzon D, et al. Drug-resistant tuberculosis: Time for visionary political leadership. Lancet Infect Dis 2013;13(6):529-39
18. Joint United Nations Programme on HIV/AIDS (UNAIDS). Treatment 2015. UNAIDS; Geneva, Switzerland: 2013
19. Kabue MM, Buck WC, Wanless SR, et al. Mortality and clinical outcomes in HIV-infected children on antiretroviral therapy in Malawi, Lesotho, and Swaziland. Pediatrics 2012;130(3):e591-9
20. Aledort JE, Ronald A, Le Blancq SM, et al. Reducing the burden of HIV/AIDS in infants: The contribution of improved diagnostics. Nature 2006;444(Suppl 1): 19-28
21. HIV/AIDS diagnostics technology landscape-semi-Annual update. UNITAID. Available from: Www.unitaid.eu/images/UNITAID-2013-Semi-Annual- Update-HIV-Diagnostics-Technology- Landscape.pdf [Last accessed November 2013]
22. Corbett EL, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in sub-Saharan Africa: Opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 2006;367(9514):926-37
23. McNerney R, Maeurer M, Abubakar I, et al. Tuberculosis diagnostics and biomarkers: Needs, challenges, recent advances, and opportunities. J Infect Dis 2012;205(Suppl 2):S147-58
24. World Health Organisation. Global Tuberculosis Report 201. WHO; Geneva, Switzerland: 2013
25. Keeler E, Perkins MD, Small P, et al. Reducing the global burden of tuberculosis: The contribution of improved diagnostics. Nature 2006;444(Suppl 1):49-57
26. World Health Organisation. Strategic and technical advisory group for tuberculosis report of 10th meeting. WHO; Geneva, Switzerland; 2010
27. Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: A multicentre implementation study. Lancet 2011;377(9776):1495-505
28. Theron G, Zijenah L, Chanda D, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: A multicentre, randomised, controlled trial. Lancet 2014;383(9915): 424-35
29. Zumla A, Abubakar I, Raviglione M, et al. Drug-resistant tuberculosis-current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis 2012; 205(Suppl 2):S228-40
30. WHO. Available from: Http://apps.who.int/gho/data/view.main.CMNRWORLD- CH9?. lang=en [Last accessed 9 January 2014]
31. Lim YW, Steinhoff M, Girosi F, et al. Reducing the global burden of acute lower respiratory infections in children: The contribution of new diagnostics. Nature 2006;444(Suppl 1):9-18
32. Kashinkunti MD, Gundikeri SK, Dhananjaya M. Acute undifferentiated febrile illness-clinical spectrum and outcome from a tertiary care teaching hospital of north Karnataka. Indian J Biol Med Res 2013;4(2):3399-402
33. Reyburn H, Mbakilwa H, Mwangi R, et al. Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: Randomised trial. BMJ 2007;334(7590):403
34. Gething PW, Kirui VC, Alegana VA, et al. Estimating the number of paediatric fevers associated with malaria infection presenting to Africa's public health sector in 2007. PLoS Med 2010;7(7):e1000301
35. Aledort JE, Ronald A, Rafael ME, et al. Reducing the burden of sexually transmitted infections in resource-limited settings: The role of improved diagnostics. Nature 2006; 444(Suppl 1):59-72
36. Peeling RW, Ronald A. Diagnostic challenges of sexually transmitted infections in resource-limited settings. Future Microbiol 2009;4(10):1271-82
37. Tucker JD, Bien CH, Peeling RW. Point-of-care testing for sexually transmitted infections: Recent advances and implications for disease control. Curr Opin Infect Dis 2013;26(1):73-9
38. Brent AJ, Ahmed I, Ndiritu M, et al. Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: Community-based observational study. Lancet 2006;367(9509): 482-8 (Pubitemid 43208904
39. Berkley JA, Lowe BS, Mwangi I, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 2005;352(1):39-47 (Pubitemid 40075679
40. Zhou XN, Xu J, Chen HG, et al. Tools to support policy decisions related to treatment strategies and surveillance of Schistosomiasis japonica towards elimination. PLoS Negl Trop Dis 2011;5(12):e1408
41. Solomon AW, Engels D, Bailey RL, et al. A diagnostics platform for the integrated mapping, monitoring, and surveillance of neglected tropical diseases: Rationale and target product profiles. PLoS Negl Trop Dis 2012;6(7):e1746
42. Grigorenko E, Fisher C, Patel S, et al. Multiplex screening for blood-borne viral, bacterial, and protozoan parasites using an OpenArray platform. J Mol Diagn 2014; 16(1):136-44
43. Cunningham J, Hasker E, Das P, et al. A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis. Clin Infect Dis 2012;55(10):1312-19
44. Chappuis F, Sundar S, Hailu A, et al. Visceral leishmaniasis: What are the needs for diagnosis, treatment and control?. Nat Rev Microbiol 2007;5(11):873-82 (Pubitemid 47578388
45. Cota GF, de Sousa MR, Demarqui FN, Rabello A. The diagnostic accuracy of serologic and molecular methods for detecting visceral leishmaniasis in HIV infected patients: Meta-Analysis. PLoS Negl Trop Dis 2012;6(5):e1665
46. malERA Consultative Group on Diagnoses, Diagnostics. A research agenda for malaria eradication: Diagnoses and diagnostics. PLoS Med 2011;8(1):e1000396
47. Bejon P, Mwangi I, Ngetsa C, et al. Invasive Gram-negative bacilli are frequently resistant to standard antibiotics for children admitted to hospital in Kilifi, Kenya. J Antimicrob Chemother 2005;56(1):232-5 (Pubitemid 41418364
48. Gordon MA, Graham SM, Walsh AL, et al. Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin Infect Dis 2008; 46(7):963-9 (Pubitemid 351589858
49. Blomberg B, Manji KP, Urassa WK, et al. Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: A prospective cohort study. BMC Infect Dis 2007;7:43
50. Castan P, de Pablo A, Fernandez-Romero N, et al. Point-of-Care System for Detection of Mycobacterium tuberculosis and Rifampin Resistance in Sputum Samples. J Clin Microbiol 2014;52(2):502-7
51. Huletsky A, Lebel P, Picard FJ, et al. Identification of methicillin-resistant Staphylococcus aureus carriage in less than 1 hour during a hospital surveillance program. Clin Infect Dis 2005;40(7):976-81 (Pubitemid 40418304
52. Bergval I, Sengstake S, Brankova N, et al. Combined species identification, genotyping, and drug resistance detection of Mycobacterium tuberculosis cultures by MLPA on a bead-based array. PLoS One 2012;7(8):e43240
53. Urdea M, Penny LA, Olmsted SS, et al. Requirements for high impact diagnostics in the developing world. Nature 2006; 444(Suppl 1):73-9
54. Denkinger CM, Nicolau I, Ramsay A, et al. Are peripheral microscopy centres ready for next generation molecular tuberculosis diagnostics?. Eur Respir J 2013;42(2):544-7
55. Curtis KA, Rudolph DL, Nejad I, et al. Isothermal amplification using a chemical heating device for point-of-care detection of HIV-1. PLoS One 2012;7(2):e31432
56. LaBarre P, Hawkins KR, Gerlach J, et al. A simple, inexpensive device for nucleic acid amplification without electricity-Toward instrument-free molecular diagnostics in low-resource settings. PLoS One 2011;6(5): E19738
57. Abd El Wahed A, El-Deeb A, El-Tholoth M, et al. A portable reverse transcription recombinase polymerase amplification assay for rapid detection of foot-And-mouth disease virus. PLoS One 2013;8(8):e71642
58. Lewandrowski K, Gregory K, Macmillan D. Assuring quality in point-of-care testing: Evolution of technologies, informatics, and program management. Arch Pathol Lab Med 2011;135(11):1405-14
59. Basu S, Chatterjee S, Bandyopadhyay A, Sarkar K. Potential application of superparamagnetic nanoparticles for extraction of bacterial genomic DNA from contaminated food and environmental samples. J Sci Food Agric 2013;93(4): 788-93
60. Chung HJ, Castro CM, Im H, et al. A magneto-DNA nanoparticle system for rapid detection and phenotyping of bacteria. Nat Nanotechnol 2013;8(5):369-75
61. Lee H, Sun E, Ham D, Weissleder R. Chip-NMR biosensor for detection and molecular analysis of cells. Nat Med 2008; 14(8):869-74
62. Tan E, Wong J, Nguyen D, et al. Isothermal DNA amplification coupled with DNA nanosphere-based colorimetric detection. Anal Chem 2005;77(24):7984-92 (Pubitemid 41831983
63. Baptista PV, Koziol-Montewka M, Paluch-Oles J, et al. Gold-nanoparticleprobe-based assay for rapid and direct detection of Mycobacterium tuberculosis DNA in clinical samples. Clin Chem 2006; 52(7):1433-4 (Pubitemid 43956043
64. Neely LA, Audeh M, Phung NA, et al. T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci Transl Med 2013;5(182):182ra154
65. Hahm J. Lieber. Direct ultrasensitive electrical detection of DNA and DNA sequence variations using nanowire nanosensors. Nano Lett 2003;4(1):51054
66. Lutz S, Weber P, Focke M, et al. Microfluidic lab-on-A-foil for nucleic acid analysis based on isothermal recombinase polymerase amplification (RPA). Lab Chip 2010;10(7):887-93
67. Mauk MG, Liu C-C, Corstjens PLAM, Bau HH. Streamlining POC microfluidic molecular diagnostics. IVD Technology 2011;17(6):22-8
68. Rozand C. Paper-based analytical devices for point-of-care infectious disease testing. Eur J Clin Microbiol Infect Dis 2014;33(2): 147-56
69. Chen D, Mauk M, Qiu X, et al. An integrated, self-contained microfluidic cassette for isolation, amplification, and detection of nucleic acids. Biomed Microdevices 2010;12(4):705-19
70. Chen Z, Mauk MG, Wang J, et al. A microfluidic system for saliva-based detection of infectious diseases. Ann N Y Acad Sci 2007;1098:429-36 (Pubitemid 47092545
71. Klostranec JM, Xiang Q, Farcas GA, et al. Convergence of quantum dot barcodes with microfluidics and signal processing for multiplexed high-Throughput infectious disease diagnostics. Nano Lett 2007;7(9): 2812-18 (Pubitemid 47522443
72. Palamountain KM, Baker J, Cowan EP, et al. Perspectives on introduction and implementation of new point-of-care diagnostic tests. J Infect Dis 2012; 205(Suppl 2):S181-90
73. McNerney R, Daley P. Towards a point-of-care test for active tuberculosis: Obstacles and opportunities. Nat Rev Microbiol 2011;9(3):204-13
74. Peeling R, McNerney R. Increasing access to diagnostics through technology transfer and local production. WHO; Geneva, Switzerland: 2011
75. McNerney R, Sollis K, Peeling RW. Improving access to new diagnostics through harmonised regulation: Priorities for action. Afr J Lab Med 2014. 3(1):p. 7
76. The International Diagnostics Centre. Available from: Www.idc-dx.org/resources?. tid-1[]=26&keys= [Last accessed 12 January 2014]
77. IMDRF. Available from: Www.imdrf.org/workitems/wi-mdsap.asp [Last accessed 13 January 2014]
78. AHWP. Available from: Www.ahwp.info/ [Last accessed 12 January 2014]
79. PAHWP. Available from: Www.pahwp.org/ [Last accessed 12 January 2014]
80. ALADDiV. Available from: Http://en. aladdiv.org.br/ [Last accessed 28 March 2014]
81. WHO. Tuberculosis. Available from: Http://who.int/tb/laboratory/ mtbrifrollout/en/ [Last accessed 13 January 2014]